Despite an over 80% rise in less than 2 months, Motilal Oswal says buy this newly-listed stock - Reason, target price
A ipo & listings development with market-wide reach.
6 Oct 2026 · LiveMint Markets
Molbio Diagnostics share price was listed on the Indian bourses on 17 August this year. At the current market price of ₹1,475.50, it is up 83% from its IPO price of ₹807 in less than two months.
Key facts
- Dates in focus
- 17 August
The analysis
Listing activity is a read on risk appetite — a hot primary market usually means a confident secondary one.
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Market context
- This is a market-wide development — its reach goes beyond any single stock.
Related coverage
Jio IPO likely by Oct end at enterprise valuation of above ₹12 trillion
Jio IPO GMP latest price today: Grey market premium is rising day by day - Check expected price band
Wizz Financial bets on India with cross-border fintech push, eyes 2029 IPO
Reliance Jio IPO: Rs 37,700 crore mega issue, full schedule & 5 must-know details
Kanohar Electricals soars 20%; stock up 79% from IPO price in three weeks